Atlas Trials

Peng Zhang

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Peng Zhang

RecordFirmDate
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC (NCT07742332)Peng Zhang2025-11-25
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer (NCT06755684)Peng Zhang2024-11-07
Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis (NCT06119490)Peng Zhang2023-07-05
Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage (NCT03523234)Peng Zhang2018-10-01
Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer (NCT03514849)Peng Zhang2018-08-01

Track Peng Zhang automatically

Every clearance here is in the API, with alerts when new ones post.